
Ranjit Kumar Sahoo
@RanjitKSMD
Followers
2K
Following
3K
Media
42
Statuses
797
Medical Oncologist, AIIMS, New Delhi, India. Opinions are my own.
New Delhi
Joined January 2020
RT @Deba_91: Glad to share our experience on umbilical cord blood transplant at @aiims_newdelhi, the 1st such data….
link.springer.com
Indian Pediatrics - There is dearth of clinical data from India regarding outcomes of umbilical cord blood transplant (UCBT). This study aimed to analyze the long-term outcomes in children who...
0
1
0
Inflammation and the Hematologic Spectrum: CHIP, CCUS, MDS, and CMML — Another example of “The Inflammation-to-Cancer Continuum”.
I always consider hematologic malignancy in a suspected vasculitis diagnosis- ideally with @CarrawayHetty @ACR_Journals
0
0
4
Erdheim Chester Disease.
Case Record of the Massachusetts General Hospital: A 63-Year-Old Woman with Dyspnea on Exertion . #MedTwitter #Cardiology
0
0
4
RT @rudra09s025: 📢 Now available online !.Full article : Comparable response rates of venetoclax 50 mg with posaconazole versus venetoclax….
0
27
0
RT @DrYukselUrun: Time to rethink cancer trials. 🧬 Precision oncology demands:.-Early molecular profiling.-Flexible evidence (Phase 1/2, re….
0
45
0
RT @MathewsVikram: Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trial: Mole….
cell.com
POC manufactured CAR-T cell therapy demonstrates a higher CR rate and presents a promising therapeutic option for low- and middle-income countries like India. The total cost of CAR-T cell therapy,...
0
26
0
Many congratulations. So proud of you.
Honored to present 2 abstracts @ #Tandem2025, representing @AIIMS_NewDelhi on a global stage in Hawaii! Grateful to my teachers @drsameerbakhshi @RanjitKSMD @DeepamPushpam for the mentorship & inspiration. Excited to contribute to #BMT #ASTCT #Tandem25 @pho_india
2
1
20
Thanks dear. Let’s keep our fingers crossed.
Congratulations! @MohiniMendirat1 and @RanjitKSMD for this amazing work. Excited to see it in a clinical trial in future. 👏 #Tandem25
0
2
13
Prof Smita Bhatia has joined as the “Infosys Chair in Oncology” at AIIMS @SmitaBhatia10 . In this lecture she discussed about her path in medicine and personal life. At the end she told “Family is the most essential thing”@TVSVGKTILAK1 @ArunaAwasthi7 @DrGPrakash
1
3
30
“Through every challenge, we find resilience. Through every struggle, we find strength. Together, we raise awareness, inspire hope, and fight for a future without GVHD.”@MohiniMendirat1 @DrGPrakash @Prasshmehta.
February 17, 2025 is #GVHDDay, a day to honor and recognize the individuals living with Graft-versus-host disease. Living with GVHD can be overwhelming, but it's important to remember you are not alone. To learn more, visit #GVHDAlliance #ABCsOfGVHD
0
1
12
RT @faheema_hasan: Beautiful review of HLH on @NEJM from history to management of primary and secondary HLH.In the revised HLH 2024 criteri….
0
37
0
A wonderful attempt to document genotoxicity. A must read.
Great to see this published! Effect of replacing procarbazine for dacarbazine in escBEACOPP for Hodgkin Rx. Huge beneficial effect on genotoxicity. Really no role for procarbazine in front line Hodgkin. Congrats to Anna Santasieri & George Follows. #lymsm.
0
0
4
RT @graham74GC: Great to see this published! Effect of replacing procarbazine for dacarbazine in escBEACOPP for Hodgkin Rx. Huge beneficial….
thelancet.com
Procarbazine induces a higher mutation burden and novel mutational signatures in patients with Hodgkin lymphoma treated with eBEACOPP and their germline DNA, raising concerns for the genomic health...
0
18
0
RT @EricTopol: A new study this week @Nature showed how the most common blood test performed—the CBC, complete blood count—contains a treas….
0
325
0
RT @DrGPrakash: Early diagnosis of anthracycline cardiotoxicity using GLS ECHOcardiography.A prospective study. #lymsm.#MedTwitter.
0
3
0